Kevin Sullivan

Active Investor

Chief Executive Officer - Founder at 3DBioFibR Inc.

Nova Scotia

Kevin Sullivan, Chief Executive Officer - Founder at 3DBioFibR Inc. is an active investor based in Nova Scotia. This profile covers what Kevin Sullivan backs, at which stage, and how founders can reach out in 2026.

Dr. Kevin Sullivan is a Co-Founder and serves as Chief Executive Officer & Board Member at 3DBioFibR. Dr. Sullivan serves as a Board Member at Emagix. He founded and served as Chief Executive Officer and Board Member at Appili Therapeutics. He brings more than 21 years of experience working with early-stage biotechnology companies and has raised over $70 million in private equity and non-dilutive government funding in the space. Before joining Appili, he was Chief Executive Officer at DeNovaMed Inc. and Chief Operating Officer at Viron Therapeutics, which develops novel immunotherapies. He has an honors degree in Microbiology/Immunology from Dalhousie University, a graduate certificate in biotechnology from McGill University, and an MBA from the University of Western Ontario.

Investor type: Angel
Stages: Pre SeedSeed
Invests in: Healthcare & BiotechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseIoT & Connected DevicesManufacturing & Industrial
Location: Nova Scotia
Typical check: $150K
Past investments: 2

Notable investments

SweptViron Therapeutics Inc

How to reach Kevin Sullivan

Angels and operators like Kevin Sullivan reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Kevin Sullivan invest in?

Kevin Sullivan invests in Healthcare & Biotech, Biotech & Pharma, MedTech & Medical Devices and SaaS & Enterprise, typically at Pre Seed and Seed. Match your sector and stage, then reach out with a personalized pitch.